Galenica Sustainability and Business Performance

About Galenica Market environment Business performance Governance Sustainability Outlook Products & Brands: exceptionally strong sales growth Net sales (in million CHF) 132 +26.0% 27 ■International 75 60 Swiss 13 market 104 13 62 46 2021 H1 2021 H1 2022 Expansion effect +32.0% +13.0% 08.08.2022 54 Key growth drivers VERFORA Triofan High demand for cough and cold medications & travel-related products Triofan C Expansion of product portfolio NATURE AND ANTI BR Algifor Liquid caps 400 buprofen 400 mg Schmerzmittel mit entrinding hemender und bebersenkender Wikurg 10 Weichgativekpoin VERFORA VICKS VICKS VapoRub VICKS VapoRub Sale Onguent " SPAGYROS Ribes nigrum 500 1E/Tropfen Vitamin D3 Wild 이 Cholecalorum Vitamin D3 Wild Cha WID GALENICA

View entire presentation